Open Orphan plc
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker an… Read more
Open Orphan plc (OPORF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.173x
Based on the latest financial reports, Open Orphan plc (OPORF) has a cash flow conversion efficiency ratio of -0.173x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.53 Million) by net assets ($43.63 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Open Orphan plc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Open Orphan plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Open Orphan plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Open Orphan plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OrganiGram Holdings Inc
NASDAQ:OGI
|
-0.043x |
|
NervGen Pharma Corp
OTCQB:NGENF
|
1.808x |
|
UNISEM Co. Ltd
KQ:036200
|
0.022x |
|
Richardson Electronics Ltd
NASDAQ:RELL
|
-0.001x |
|
Vinte Viviendas Integrales S.A.B. de C.V
MX:VINTE
|
-0.033x |
|
Global Standard Technology Limited
KQ:083450
|
0.015x |
|
Avita Medical Ltd
NASDAQ:RCEL
|
0.327x |
|
Hi-Lex Corporation
PINK:HLXFF
|
N/A |
Annual Cash Flow Conversion Efficiency for Open Orphan plc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Open Orphan plc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $44.67 Million | $10.34 Million | 0.231x | -53.93% |
| 2023-12-31 | $34.33 Million | $17.24 Million | 0.502x | -36.46% |
| 2022-12-31 | $20.22 Million | $15.98 Million | 0.790x | +1145.15% |
| 2021-12-31 | $20.68 Million | $-1.56 Million | -0.076x | -140.43% |
| 2020-12-31 | $22.30 Million | $4.17 Million | 0.187x | +119.28% |
| 2019-12-31 | $2.86 Million | $-2.78 Million | -0.970x | -282.82% |
| 2018-12-31 | $3.93 Million | $-996.14K | -0.253x | -68.26% |
| 2017-12-31 | $7.77 Million | $-1.17 Million | -0.151x | -356.88% |
| 2016-12-31 | $8.89 Million | $-293.23K | -0.033x | +84.31% |
| 2015-12-31 | $7.55 Million | $-1.59 Million | -0.210x | +63.17% |
| 2014-12-31 | $1.41 Million | $-803.14K | -0.570x | +77.87% |
| 2013-12-31 | $603.77K | $-1.56 Million | -2.578x | -677.20% |
| 2012-12-31 | $2.07 Million | $-686.62K | -0.332x | -103.81% |
| 2011-12-31 | $104.35K | $907.41K | 8.696x | -- |